Gastroenterology Advisor (6/27, Nye) reported a study found that “pancreatic cancer (PC) risk is significantly higher among individuals with cystic fibrosis (CF) or gene variants in cystic fibrosis transmembrane conductance regulator (CFTR).” The researchers sourced data “from Kaiser Permanente Southern California (KPSC), a large integrated health care system.” They found that the “incidence rate (IR) of PC was higher among the CF cohort than the general KPSC population among adults aged 50 years and older, whereas the IR was similar for younger individuals, respectively.” Furthermore, among the CF group, “the highest incidence of PC was observed among men aged 50 years and older with a CFTR variant, followed by women aged 50 years and older diagnosed with CF, women aged 50 years and older with a CFTR variant, men aged 50 years and older diagnosed with CF, and women aged less than 50 years who tested positive for CF.” The study was published in Clinical and Translational Gastroenterology.